Helen Collins

Helen Collins

Chief Tech/Sci/R&D Officer chez ENLIVEN THERAPEUTICS, INC.

Fortune : - $ au 31/03/2024

61 ans
Health Technology
Consumer Services
Health Services

Profil

Helen Collins is the founder of North Bay Cancer Alliance, Inc. She currently holds positions as an Independent Director at Kura Oncology, Inc., Director at IO Biotech, Inc., and Chief Medical Officer at Enliven Therapeutics, Inc. Her former positions include Chief Medical Officer & Executive Vice President at Five Prime Therapeutics, Inc. and President at Redwood Regional Medical Group, Inc. She received her undergraduate degree from Bryn Mawr College in 1984 and her doctorate from The Johns Hopkins University School of Medicine.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/05/2023 0 ( -.--% ) - $ 31/03/2024
11/04/2024 0 ( -.--% ) - $ 31/03/2024

Postes actifs de Helen Collins

SociétésPosteDébut
KURA ONCOLOGY, INC. Director/Board Member 29/07/2021
ENLIVEN THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 23/02/2023
IO BIOTECH, INC. Director/Board Member 09/11/2023
Tous les postes actifs de Helen Collins

Anciens postes connus de Helen Collins

SociétésPosteFin
FIVE PRIME THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 16/04/2021
President 01/01/2009
Founder -
Voir l'expérience en détail de Helen Collins

Formation de Helen Collins

Bryn Mawr College Undergraduate Degree
The Johns Hopkins University School of Medicine Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Helen Collins

Relations

81

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
KURA ONCOLOGY, INC.

Health Technology

IO BIOTECH, INC.

Health Technology

ENLIVEN THERAPEUTICS, INC.

Health Technology

Entreprise privées3

Health Technology

Health Services

Commercial Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Helen Collins